Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma

Case Report: Exceptional response to nivolumab plus cabozantinib in a patient with extrarenal clear cell renal cell carcinoma

Extrarenal clear cell renal cell carcinoma (eccRCC) is a rare type of RCC that arises in areas other than the kidney. Given its rarity, consensus guidelines for optimal treatment of eccRCC have not been established, and the literature is lacking any reports of patient response to systemic therapy an...

Full description

Bibliographic Details
Main Authors: Caroline S. Jansen, Yujin Choi, Sean T. Evans, Rachel Greenwald, Joseph A. Behnke, Caitlin Hartman, Haydn Kissick, Lara R. Harik, Mehmet Asim Bilen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Oncology
Subjects:
case report
extrarenal clear cell renal cell carcinoma
splenic renal cell carcinoma
nivolumab
cabozantinib
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1271255/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1271255/full

Similar Items